Differentiation Syndrome in Promyelocytic Leukemia: Clinical Presentation, Pathogenesis and Treatment

Differentiation syndrome (DS) represents a life-threatening complication in patients with acute promyelocytic leukemia (APL) undergoing induction therapy with all-trans retinoic acid (ATRA) or arsenic trioxide (ATO). It affected about 20–25% of all patients and so far there are no definitive diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Rego, E.M., De Santis, G.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2011
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219650/
https://www.ncbi.nlm.nih.gov/pubmed/22110898
http://dx.doi.org/10.4084/MJHID.2011.048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219650/
https://www.ncbi.nlm.nih.gov/pubmed/22110898
http://dx.doi.org/10.4084/MJHID.2011.048

Ejemplares similares